Article and Video CATEGORIES
Abdul Rafeh Naqash is an advanced fellow in the Early Clinical Trials Development Program and the Developmental Therapeutics Clinic at the National Cancer Institute, Bethesda.
Dr. Rafeh Naqash, one of the participants in the GRACE Patient Education Ambassador Program, shares a fantastic video series on understanding clinical trials.
For this series, Dr. Naqash speaks with Ivy Elkins, Patient Advocate and Lung Cancer Survivor and founder of the EGFR Resisters Patient Group, (https://egfrcancer.org/founders/) and Fumiko Chino, MD, a Radiation Oncologist with Memorial Sloan Kettering Cancer Center (https://www.mskcc.org/cancer-care/doctors/fumiko-chino).
In these first videos, Drs. Naqash and Chino and Ms. Elkins discuss:
-
the phases of clinical trials and what they mean
- how medical data will be used and if it would be used without the participant's knowledge
- whether clinical trials are only for people who have no other options
- eligibility for clinical trials
- what a ‘first-in-human' trial means, and whether participants are a ‘guinea pig’
#clinicaltrial #genentech #lilly #cancerGRACE
To join the conversation, visit https://cancergrace.org/forum.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…